Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3116 Neoplasms 2459 Carcinoma, Non-Small-Cell Lung 1858 Prostatic Neoplasms 1623 Colorectal Neoplasms 1401 Lung Neoplasms 1293 Multiple Myeloma 930 Neoplasm Metastasis 919 Leukemia, Myeloid, Acute 879 Pancreatic Neoplasms 853 Ovarian Neoplasms 800 Melanoma 782 Carcinoma, Hepatocellular 733 Stomach Neoplasms 647 Squamous Cell Carcinoma of Head and Neck 635 Recurrence 635 Brain Neoplasms 624 Head and Neck Neoplasms 598 Glioblastoma 558 Lymphoma 549 Uterine Cervical Neoplasms 535 Triple Negative Breast Neoplasms 511 Precursor Cell Lymphoblastic Leukemia-Lymphoma 509 Carcinoma, Renal Cell 501 Hematologic Neoplasms 464 Urinary Bladder Neoplasms 460 Endometrial Neoplasms 457 Colonic Neoplasms 445 Sarcoma 433 Lymphoma, Non-Hodgkin 432

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Non-Small Cell Lung Cancer × 1 year × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡